![Andrea Brundin](/newimages/person-profile/2022b/andrea-brundin.x6cd2fd36.jpg?w=212&h=206&crop=160,160,23,4&f=webp)
Research
![Translational Pathology hero](/newimages/research/hero/translational-pathology-hero.x923dcd07.png?w=1502&h=440&crop=780,440,361,0&width=380&height=215&fit=crop&f=webp)
Translational Pathology
We study how breast cancer spreads (‘metastasis’) through axillary (armpit) lymph nodes (ALN).
![cancer bioinformatics](/newimages/folsm/hero-banner/scps/cancer-bioinformatics.xb1b1d534.png?w=1584&h=440&crop=780,440,402,0&width=380&height=215&fit=crop&f=webp)
Cancer Bioinformatics
The Cancer Bioinformatics group is exploring molecular determinants at the primary tumour site and in the draining lymph nodes, mainly in triple negative breast cancers.
Research
![Translational Pathology hero](/newimages/research/hero/translational-pathology-hero.x923dcd07.png?w=1502&h=440&crop=780,440,361,0&width=380&height=215&fit=crop&f=webp)
Translational Pathology
We study how breast cancer spreads (‘metastasis’) through axillary (armpit) lymph nodes (ALN).
![cancer bioinformatics](/newimages/folsm/hero-banner/scps/cancer-bioinformatics.xb1b1d534.png?w=1584&h=440&crop=780,440,402,0&width=380&height=215&fit=crop&f=webp)
Cancer Bioinformatics
The Cancer Bioinformatics group is exploring molecular determinants at the primary tumour site and in the draining lymph nodes, mainly in triple negative breast cancers.